Palladone Phased Launch Should Collect One Year Of Abuse Data, Cmte. Says

The first phase of launch for Purdue's Palladone (hydromorphone) should collect data on abuse and diversion for a year, FDA's Anesthetic & Life Support Advisory Committee recommended Sept. 10